Drug Profile
DTwP-HebB-Hib vaccine - Sanofi
Alternative Names: Diphtheria, Tetanus, Pertussis, Haemophilus influenza B, and Hepatitis B vaccine - Sanofi; Hib-DTP-hepatitis-B vaccine - Sanofi; Pentavalent vaccine - Sanofi; Shan 5; Shan5Latest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Shantha Biotechnics
- Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
Most Recent Events
- 05 May 2014 Shan5™ receives WHO prequalification status for the prevention of Diptheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B
- 31 Mar 2014 Registered for Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention) in India (IM)
- 03 Sep 2012 Phase-III clinical trials in Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention) in India (IM)